Envestnet Asset Management Inc Atea Pharmaceuticals, Inc. Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023
BUY
$4.35 - $6.17 $10,848 - $15,387
2,494 Added 14.11%
20,173 $97,000
Q3 2022

Nov 10, 2022
BUY
$5.49 - $8.79 $3,140 - $5,027
572 Added 3.34%
17,679 $101,000
Q2 2022

Aug 03, 2022
BUY
$5.33 - $8.18 $12,845 - $19,713
2,410 Added 16.4%
17,107 $121,000
Q1 2022

May 04, 2022
BUY
$5.5 - $9.19 $80,833 - $135,065
14,697 New
14,697 $106,000

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $270M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email